Nevertheless, though recommending caution to use their study to guide clinical practice, Zhao et al. (2020a, b) have speculated on possible clinical consequences of their findings as introducing ABO typing into the routine part of management of COVID-19 and considering a more aggressive treatment. The gene discussed is ABO; the disease is COVID-19.